Comparison of Trough Level- and Clinical-based Spacing of Infliximab Infusions in Patients With IBD in Deep Remission
Condition: Inflammatory Bowel Diseases · Sponsor: University Hospital, Montpellier
About this study
Comparison of trough level-based spacing and clinical-based spacing of infliximab infusions in patients with inflammatory bowel disease in deep remission A prospective, multicenter, open-label, randomized, controlled Study
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (16)
| Amiens University Hospital | Amiens, France | — |
| Besançon University Hospital | Besançon, France | — |
| Bordeaux University Hospital | Bordeaux, France | — |
| Caen University Hospital | Caen, France | — |
| Clermont-Ferrand University Hospital | Clermont-Ferrand, France | — |
| Lille University Hospital | Lille, France | — |
| Pineton de Chambrun | Montpellier, France | — |
| CHRU Nancy - Hôpitaux de Brabois | Nancy, France | — |
| Nantes University Hospital | Nantes, France | — |
| Nice University Hospital | Nice, France | — |
| Nîmes University Hospital | Nîmes, France | — |
| APHP Beaujon Hospital | Paris, France | — |
+ 4 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03841942